Jillian Moore, MD | |
Route 301 North, Zuni, NM 87327-0467 | |
(505) 782-7449 | |
Not Available |
Full Name | Jillian Moore |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 6 Years |
Location | Route 301 North, Zuni, New Mexico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588160477 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD2020-0937 (New Mexico) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (New Mexico) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Zuni Comprehensive Community Health Center | Zuni, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Zuni Indian Hospital | 5698689644 | 57 |
News Archive
Even the simplest networks of neurons in the brain are composed of millions of connections, and examining these vast networks is critical to understanding how the brain works.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare brand, today announced fourth quarter revenues of $25.5 million and a net loss of $19.2 million, or $0.11 per share, which compares to revenue of $25.9 million and a net loss of $36.7 million, or $0.27 per share for the same period in the fiscal 2009.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
The human brain's ability to recall a single movement is significantly affected by the characteristics of previous actions it was learned with, a new study has shown.
› Verified 7 days ago
Entity Name | Dhhs,phs,naihs, Gallup Indian Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225002322 PECOS PAC ID: 3173436409 Enrollment ID: O20031111000840 |
News Archive
Even the simplest networks of neurons in the brain are composed of millions of connections, and examining these vast networks is critical to understanding how the brain works.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare brand, today announced fourth quarter revenues of $25.5 million and a net loss of $19.2 million, or $0.11 per share, which compares to revenue of $25.9 million and a net loss of $36.7 million, or $0.27 per share for the same period in the fiscal 2009.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
The human brain's ability to recall a single movement is significantly affected by the characteristics of previous actions it was learned with, a new study has shown.
› Verified 7 days ago
Entity Name | Zuni Indian Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497843734 PECOS PAC ID: 5698689644 Enrollment ID: O20031114000284 |
News Archive
Even the simplest networks of neurons in the brain are composed of millions of connections, and examining these vast networks is critical to understanding how the brain works.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare brand, today announced fourth quarter revenues of $25.5 million and a net loss of $19.2 million, or $0.11 per share, which compares to revenue of $25.9 million and a net loss of $36.7 million, or $0.27 per share for the same period in the fiscal 2009.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
The human brain's ability to recall a single movement is significantly affected by the characteristics of previous actions it was learned with, a new study has shown.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Jillian Moore, MD Po Box 467, Zuni, NM 87327-0467 Ph: (505) 782-4431 | Jillian Moore, MD Route 301 North, Zuni, NM 87327-0467 Ph: (505) 782-7449 |
News Archive
Even the simplest networks of neurons in the brain are composed of millions of connections, and examining these vast networks is critical to understanding how the brain works.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare brand, today announced fourth quarter revenues of $25.5 million and a net loss of $19.2 million, or $0.11 per share, which compares to revenue of $25.9 million and a net loss of $36.7 million, or $0.27 per share for the same period in the fiscal 2009.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
The human brain's ability to recall a single movement is significantly affected by the characteristics of previous actions it was learned with, a new study has shown.
› Verified 7 days ago
Angelina Shigeura, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North B Street, Zuni, NM 87327 Phone: 505-782-7450 | |
Rebecca H Ryan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Route 301 N 21 B Ave, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Dr. Nadra Crawford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Karthik Kavasseri, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Dr. Emma Oberlander, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Route 301 North, Zuni, NM 87327 Phone: 505-782-4431 Fax: 505-782-4502 | |
Ashwini Mathai, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: Route 301 N 21 B Avenue, Zuni, NM 87327 Phone: 505-782-4431 | |
Kristen Lenore Zozulin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Rte 301 N 21b Ave, Zuni, NM 87327 Phone: 505-782-7456 |